EIM
SUPN icon

Essex Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Essex Investment Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-63,754
Closed -$3.21M – 526
2018
Q3 		$3.21M Buy
63,754
+2,042
+3% +$101K 0.38% 70
2018
Q2 		$3.69M Buy
61,712
+59
+0.1% +$3.06K 0.46% 56
2018
Q1 		$2.82M Sell
61,653
-3,508
-5% -$146K 0.37% 78
2017
Q4 		$2.6M Buy
65,161
+1,917
+3% +$75.8K 0.34% 83
2017
Q3 		$2.53M Sell
63,244
-13,535
-18% -$586K 0.34% 77
2017
Q2 		$3.31M Buy
76,779
+17,417
+29% +$620K 0.47% 49
2017
Q1 		$1.86M Buy
59,362
+8,920
+18% +$239K 0.29% 100
2016
Q4 		$1.27M Buy
50,442
+3,267
+7% +$73K 0.21% 128
2016
Q3 		$1.17M Sell
47,175
-50,688
-52% -$1.15M 0.19% 134
2016
Q2 		$1.99M Sell
97,863
-8,542
-8% -$152K 0.33% 81
2016
Q1 		$1.62M Buy
106,405
+15,777
+17% +$206K 0.28% 85
2015
Q4 		$1.22M Sell
90,628
-5,403
-6% -$83.6K 0.19% 126
2015
Q3 		$1.35M Buy
96,031
+3,987
+4% +$74.1K 0.22% 104
2015
Q2 		$1.56M Sell
92,044
-1,937
-2% -$27.6K 0.24% 104
2015
Q1 		$1.14M Sell
93,981
-729
-0.8% -$6.89K 0.16% 136
2014
Q4 		$786K Sell
94,710
-14,420
-13% -$121K 0.11% 188
2014
Q3 		$948K Buy
+109,130
New +$986K 0.15% 162

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Essex Investment Management's SUPN Position: Q4 2018 in Review

Essex Investment Management sold out of Supernus Pharmaceuticals (SUPN) in Q4 2018, closing a stake of 63,754 shares — an estimated $3.21M sold.

Essex Investment Management first reported a position in SUPN in Q3 2014 and held it in 17 quarters. The position peaked at $3.69M in Q2 2018. 274 funds tracked by Wall St. Rank hold SUPN as of Q4 2018.

  • Essex Investment Management reported no remaining Supernus Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Essex Investment Management sold 63,754 Supernus Pharmaceuticals shares in Q4 2018, an estimated $3.21M.
  • Essex Investment Management first reported a position in Supernus Pharmaceuticals in Q3 2014 and held it in 17 quarters.
  • Essex Investment Management's Supernus Pharmaceuticals position peaked at $3.69M in Q2 2018.
  • 274 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2018.

Based on Essex Investment Management's 13F filing for Q4 2018, filed 6 Feb 2019.